HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday 16 January 2018

NHS England consultations…

…on several Specialised Services clinical commissioning policies are open.  These proposals are based on a ‘rapid HTA process’ which was parly informed by work in HEDS.  The policies are:
  • Specialised Services clinical commissioning policy: Hyperbaric Oxygen Therapy for Carbon Monoxide Poisoning
  • Specialised Services clinical commissioning policy: Hyperbaric Oxygen Therapy for Decompression Illness/Gas Embolism
  • Specialised Services clinical commissioning policy: Anakinra to treat periodic fevers and autoinflammatory diseases (all ages)
  • Specialised Services clinical commissioning policy: Hyperbaric Oxygen Therapy for soft tissue radiation damage in patients with a history of pelvic irradiation for malignant disease
  • Specialised Services clinical commissioning policy: Anakinra/Tocilizumab for the treatment Adult Onset Still’s Disease refractory to second-line therapy (adults)
  • Adult Onset Still’s Disease refractory to methotrexate and corticosteroids. Related documents Anakinra/Tocilizumab... More
  • Specialised Services clinical commissioning policy: Deep Brain Stimulation for Refractory Tourette Syndrome in adults
  • Specialised Services clinical commissioning policy: Hyperbaric Oxygen Therapy for Malignant Otitis Externa
More details here

Posted by at